AACAP regularly provides input on the implementation of federal laws related to child psychiatry and children's mental health by providing comments to federal agencies during the development of regulations.

Choose a Year

2026

• AACAP Responds to the Proposed Prohibition on Medicaid and CHIP Funding for Gender Affirming Care for Children
  February 17, 2026
• AACAP Responds to Proposed Changes to Medicare and Medicaid Conditions of Participation Prohibiting Gender-Affirming Care Procedures for Children
  February 17, 2026

2025

• AACAP Submits Comments to CMS on its Medicare Physician Fee Schedule Proposals for Calendar Year 2026
  September 10, 2025
• AACAP Submits Comments to DEA on its Proposals for a Special Registration for the Prescription of Controlled Substances via Telemedicine
  March 18, 2025

2024

• AACAP Submits Comments to CMS on Documenting Mental Health Parity Compliance in Medicaid and CHIP
  December 2, 2024
• AACAP Submits Comments to the Food and Drug Administration on the Clozapine REMS
  November 4, 2024
• AACAP Responds to Proposed Medicare and Medicaid CY 2025 Payment Policies under the Physician Fee Schedule
  September 9, 2024
• AACAP Provides Comments to DEA on Proposal to Reschedule Marijuana from Schedule I to Schedule III.
  July 22, 2024
• AACAP Responds to Department of Education RFI on Mental Health and Substance Use Needs in Higher Education.
  February 26, 2024

2023

• AACAP Responds to CMCS Request for Comments on Mental Health Parity Compliance in Medicaid/CHIP
  December 4, 2023
• AACAP Comments on DEA Production Quota Notice for 2024
  December 4, 2023
• AACAP Submits Comments to NTIA on Kids Online Safety
  November 16, 2023
• AACAP Comments on Requirements Related to the Mental Health Parity and Addiction Equity Act
  October 17, 2023
• AACAP Comments on Parity Technical Release
  October 17, 2023
• AACAP Comment Letter to CMS on 2024 Medicare and Fee Schedule
  September 11, 2023
• AACAP Comments on Soliciting Data on the Impact of Telehealth Initiation of Controlled Substances Under Public Health Emergency
  August 30, 2023
• AACAP Comments on Psychedelic Drugs: Considerations for Clinical Investigations
  August 25, 2023
• AACAP Comments on Assistance to States for the Education of Children with Disabilities Proposed rule
  August 1, 2023
• AACAP Comments on Medicaid and CHIP Managed Care Access, Finance, and Quality Proposed Rule
  July 3, 2023
• AACAP Comments on CMS Interoperability and Prior Authorization Proposals
  May 2, 2023
• AACAP Comments on DEA Proposals for Telemedicine Prescribing of Controlled Substances Post-Public Health Emergency
  March 29, 2023
• AACAP Comments on DEA Proposals on Induction of Buprenorphine via Telemedicine Encounter
  March 29, 2023
• AACAP Comments on Medications for the Treatment of Opioid Use Disorder
  March 1, 2023
• AACAP Comments on CCBHC Interim Draft Certification Criteria
  January 20, 2023

2022

• AACAP Comments on Section 1557 Nondiscrimination Proposed Rule
  October 3, 2022
• AACAP Comments on Revisions to Payment Policies Under the Medicare Physician Fee Schedule for CY 2023
  September 6, 2022
• AACAP Comments on Draft Recommendation Statements for Depression, Suicide Risk, and Anxiety for Children and Adolescents
  May 9, 2022

2021

• AACAP Comments on Revisions to Payment Policies under the Medicare Physician Fee Schedule for CY 2022
  September 10, 2021
• AACAP Calls for Immediate Recission of Rule That Would Remove Nondiscrimination Protections in Federal Government Grant Programs
  January 15, 2021

2020

• AACAP Comments on the HHS Proposed SUNSET Regulations
  December 4, 2020
• AACAP States Opposition to Department of Homeland Security Proposal that Would Threaten the Status of J-1 Visa Holders
  October 16, 2020
• AACAP Comments on Revisions to Payment Policies under the Medicare Physician Fee Schedule for CY 2021
  October 2, 2020
• AACAP Comments on Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency
  July 7, 2020
• AACAP Calls for Retraction of HHS Section 1557 Final Rule
  June 23, 2020
• AACAP Comments on Policy Revisions in Response to the COVID-19 Public Health Emergency
  June 10, 2020

2019

• AACAP Comments on Revisions to Payment Policies under the Medicare Physician Fee Schedule for CY 2020
  September 18, 2019
• AACAP Comments to the Office of the National Coordinator for Health Information Technology on their Draft Strategy on Reducing Regulatory and Administrative Burden Relating to the Use of Health IT and EHRs
  January 28, 2019
• AACAP Comments to the Centers for Medicare and Medicaid Services on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses Proposed Rule
  January 24, 2019

2018

• AACAP Comments to the Departments of Homeland Security and Health and Human Services on the Apprehension, Processing, Care, and Custody of Alien Minors and Unaccompanied Alien Children, Notice of Proposed Rulemaking
  November 6, 2018
• AACAP Comments to the Centers for Medicare and Medicaid Services on FY 2019 Medicare Physician Fee Schedule Proposed Rule
  September 6, 2018
• AACAP Comments to the Centers for Medicare and Medicaid Services on FY 2019 Inpatient Psychiatric Facilities Prospect Payment System and Quality Reporting Updates
  June 27, 2018
• AACAP Comments to the Centers for Medicare and Medicaid Services on Short Term Limited Duration Insurance Proposed Rule
  April 11, 2018
• AACAP Comments to the Department of Labor Concerning Association Health Plan Proposed Rule
  March 5, 2018

2017

• AACAP Comments to the Centers for Medicare and Medicaid Services on Medicare Physician Fee Schedule Proposals for 2018
  September 11, 2017
• AACAP Comments to the Department of Health and Human Services on Improving Mental Health Parity
  August 10, 2017
• AACAP Comments to the Food and Drug Administration’s request for public input on Manufacturer Communications Regarding Unapproved Uses of Approved Medical Products
  April 10, 2017
• AACAP Comments in response to the Center for Medicare and Medicaid Service’s Request for Information on Pediatric Alternative Payment Model Concepts
  April 7, 2017

2016

• AACAP Comments to the Proposed Rule “Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule and Other Provisions to Part B for CY 2017
  August 31, 2016
• AACAP Comments to the Proposed Order "Neurological Devices; Reclassification of Electroconvulsive Therapy Devices Intended for Use in Treating Severe Major Depressive Episode in Patients 18 Years of Age and Older Who Are Treatment Resistant or Require a Rapid Response; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy for Certain Specified Intended Uses" and Draft Guidance "Electroconvulsive Therapy (ECT) Devices for Class II Intended Uses: Draft Guidance for Industry, Clinicians and FDA Staff: Availability"
  March 28, 2016

2015

• AACAP Comments to the Proposed Rule "Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2016"
  September 8, 2015
• AACAP Comments the Proposed Rule “Medicaid and Children’s Health Insurance Program (CHIP) Programs; Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability”
  July 27, 2015
• AACAP Comments to CMS for the Mental Health Parity and Addiction Equity Act of 2008
  June 8, 2015

2014

• AACAP Comments on CMS' Proposed Rule on the Medicare Physician Fee Schedule Calendar Year 2015
  August 25, 2014
• AACAP Comments In Response to SAMHSA's Public Listening Session on the Confidentiality of Alcohol and Drug Abuse Patient Records
  June 25, 2014

2013

• Letter to Issuers on Federally-facilitated and State Partnership
  March 15, 2013
• AACAP Comments for the Food and Drug Administration Drug Shortages Task Force and Strategic Plan, Docket Number: FDA-2013-N-0124
  March 14, 2013

2012

• Final Rule for Payment Policies Under the Physician Fee Schedule and other Revisions to Part B for CY2012
  December 26, 2012
• Patient Protection and Affordable Care Act; Standards Related to Essential Health Benefits, Actuarial Value and Accreditation: Proposed Rule CMS-9980-P
  December 24, 2012
• Electronic Health Record Incentive Program, Stage 2
  May 7, 2012
• Transparency and Disclosure
  February 17, 2012
• Essential Health Benefits (EHB)
  January 31, 2012

2011

• Establishment of Exchanges and Qualified Health Plans; Proposed Rule CMS-9989-P
  September 28, 2011
• Medicare Shared Savings Program: Accountable Care Organizations; Proposed Rule CMS--1345--P
  June 5, 2011

2010

• File Code CMS-1345-NC; Request for Information Regarding ACOs and the Medicare Shared Savings Program
  December 3, 2010
• Docket No. SSA-2007-0101; Revised Medical Criteria for Evaluating Mental Disorders
  November 17, 2010 2010
• the Interim Final Rules for Group Health Plans and Health Insurance Issuers Relating to Coverage of Preventive Services under the Patient Protection and Affordable Care Act
  September 17, 2010
• Proposed Rule for Payment Policies under the Physician Fee Schedule and other Revisions to Part B for CY2011
  August 24, 2010
• Interim Final Rules under the Paul Wellstone-Pete Domenici Mental Health Parity and Addiction Equity Act of 2008
  May 5, 2010
• AACAP Comments to proposed rule for Electronic Health Records Incentive Program under the Centers for Medicaid and Medicare Services
  March 15, 2010

2009

• FDA Pediatric Advisory Committee Meeting
  December 8, 2009
• FDA Psychopharmacological Drugs Safety Advisory Committee Meeting
  June 9-10, 2009
• FDA Psychopharmacological Drugs Safety Advisory Committee Meeting AACAP Statement
  June 9-10, 2009
• AACAP the Implementation of the Paul Wellstone-Pete Domenici Mental Health Parity and Addiction Equity Act of 2008
  May 28, 2009
• FDA Psychopharmacologic Drugs Advisory Committee Hearing
  April 7-8, 2009

2005

• New Clarification on DEA Prescription Policy
  Aug 26, 2005
• APA/AACAP Letter to DEA on Multiple Prescriptions Policy*
  Mar 21, 2005